GPT and atrial fibrillation: Contrary to expectations, AST, ALT, and GGT were unaffected by treatment, and the lack of differences in both liver function and immune markers, coupled with no adverse effects on productivity, suggests the AF challenge was not pathogenic (at least at the dose we provided).